You searched for: robenacoxib (Maltesiska - Engelska)

robenacoxib 20 mg
20 mg

robenacoxib/pillola
robenacoxib/tablet

kull pillola fiha 6 mg robenacoxib
each tablet contains 6 mg robenacoxib

onsior 6 mg pilloli għal qtates robenacoxib
onsior 6 mg tablets for cats robenacoxib

onsior 10 mg pilloli għall- klieb robenacoxib
onsior 10 mg tablets for dogs robenacoxib

robenacoxib huwa mediċina anti-infjammatorja mhux sterojdi (nsaid).
robenacoxib is a non-steroidal anti-inflammatory drug (nsaid).

onsior 20 mg/ml soluzzjoni għal injezzjoni għal klieb u qtates robenacoxib
onsior 20 mg/ml solution for injection for cats and dogs robenacoxib

20 mg/ ml robenacoxib 1 mg/ ml sodium metabisulphite (e 223)
20 mg/ ml robenacoxib 1 mg/ ml sodium metabisulphite (e 223)

fil-qtates, robenacoxib huwa metabolizzat b’mod estensiv mill-fwied.
in cats robenacoxib is extensively metabolised by the liver.

bijotrasformazzjoni robenacoxib huwa metabolizzat b’ mod estensiv mill- fwied fil- klieb.
biotransformation robenacoxib is extensively metabolised by the liver in dogs.

il-farmakokinetika ta’ robenacoxib ma tagħmilx differenza bejn qtates irġiel u qtates nisa.
the pharmacokinetics of robenacoxib do not differ between male and female cats.

il- bijodisponibbiltà sistemika ta’ pilloli robenacoxib kienet ta’ 49% mingħajr ikel.
the systemic bioavailability of robenacoxib tablets was 49% without food.

tużax fil-każ ta’ sensittività eċċessiva għal robenacoxib jew għal xi kostitwenti tal-pilloli.
do not use in case of hypersensitivity to robenacoxib or to any of the constituents of the tablets.

robenacoxib huwa metabolizzat b’mod estensiv mill-fwied fil-qtates u fil-klieb.
robenacoxib is extensively metabolised by the liver in cats and dogs.

robenacoxib idum iktar u f’konċentrazzjonijiet ogħla f’siti ta’ infjammazzjoni milli fid-demm.
robenacoxib persists longer and in higher concentrations at sites of inflammation than in blood.

robenacoxib huwa mediċina anti-infjammatorja mhux sterojdi (nsaid) tal-klassi ta’ coxib.
robenacoxib is a non-steroidal anti-inflammatory drug (nsaid) of the coxib class.

robenacoxib jibqa’ għal ħin itwal u f’konċentrazzjonijiet ogħla f’siti ta’ infjammazzjoni milli fid- demm.
robenacoxib persists longer and at higher concentrations at sites of inflammation than in blood.

robenacoxib jitneħħa predominantament permezz tar-rotta biljari (70 %) milli permezz tal- kliewi (30%).
robenacoxib is excreted predominantly via the biliary route (70%) rather than via the kidneys (30%).

il - bijodisponibilità sistemika ta ’ pilloli robenacoxib fi klieb kienet 62% ma ’ l- ikel u 84% mingħajr ikel.
the systemic bioavailability of robenacoxib tablets in dogs was 62% with food and 84% without food.

id-doża rakkomandata ta’ robenacoxib hija 1 mg/kg ta’ piż tal-ġisem b’medda ta’ 1-2 mg/kg.
the recommended dose of robenacoxib is 1 mg/kg body weight with a range 1–2 mg/kg.